Announcements Trials
Browse Landscape

Phase

Phase NA 29Phase 2 7Phase 3 3Phase 4 2Phase EARLY_PHASE1 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Prostatic Neoplasms 2Glioma 2Smoking 1Oligodendroglioma 1Neoplasms 1Lymphoma, Mantle-Cell 1Lung Neoplasms 1Glioblastoma 1EBV-associated Tumors 1Colorectal Neoplasms 1Brain Neoplasms 1Barrett Esophagus 1Astrocytoma 1

Interventions

Oncolytic Virotherapy 2tucatinib 1trifluridine tipiracil drug combination 1tribenoside (combination) 1tribenoside 1trastuzumab deruxtecan 1tipiracil 1sotorasib 1sintilimab 1semaglutide 1regorafenib 1polyethylene glycol 400 1penpulimab 1palbociclib 1montelukast 1encorafenib 1binimetinib 1balstilimab 1adagrasib 1Trifluridine 1Tobacco Use Cessation Devices 1Tablets 1Suppositories 1Standard of Care 1Specimen Handling 1Receptor Protein-Tyrosine Kinases 1Radiosurgery 1Polyethylene Glycols 1Pentoxifylline 1Panitumumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Colorectal Neoplasms × Standard of Care × Clear all
NCT07318389 2026-02-27

ASCEND-CRC: Profiling and Targeting Dynamic Tumor Resistance in Patients With Metastatic Colorectal Cancer

M.D. Anderson Cancer Center

Phase EARLY_PHASE1 Not yet recruiting
100 enrolled
Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡